Gsk (GSK) EBITDA (2009 - 2025)
Gsk's EBITDA came in at $11.96 billion for the quarter ended Dec 31, 2025, up 504.2% from $1.98 billion a year earlier.
Analysis
Gsk (GSK) EBITDA (2009 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, Gsk's EBITDA was $15.44 billion, up 72.4% from the prior year.
- EBITDA carries a five-year compound annual growth rate of 19.1% (years ended Dec 2020 to Dec 2025).
- Going back by year, EBITDA was $8.96 billion in the year ended Dec 31, 2024 (-33.4%), $13.44 billion in the year ended Dec 31, 2023 (+10.6%), $12.15 billion in the year ended Dec 31, 2022 (+14.8%) and $10.58 billion in the year ended Dec 31, 2021 (+64.6%).
- The figure for the quarter ended Dec 31, 2025 represents the highest quarterly EBITDA since the quarter ended Dec 31, 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | -1.88 Mn |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 8.95 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 8.30 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 8.16 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 7.34 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Pfizer | 156.44 Bn | 103.79 Bn | 12.56 Bn | 7.05 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 11.96 Bn |
| Dec 31, 2024 | 1.98 Bn |
| Mar 31, 2024 | 2.59 Bn |
| Dec 31, 2023 | 2.17 Bn |
| Mar 31, 2023 | 3.31 Bn |
| Dec 31, 2022 | 2.20 Bn |
| Mar 31, 2022 | 3.64 Bn |
| Dec 31, 2021 | 6.46 Bn |
| Dec 31, 2020 | 2.66 Bn |
| Dec 31, 2019 | 3.12 Bn |
| Sep 30, 2019 | 3.28 Bn |
| Dec 31, 2018 | 2.76 Bn |
| Dec 31, 2017 | 1.85 Bn |
| Dec 31, 2016 | 721.07 Mn |
| Dec 31, 2012 | 5.40 Bn |
| Dec 31, 2011 | 14.51 Bn |
| Dec 31, 2010 | 2.15 Bn |
| Dec 31, 2009 | 6.92 Bn |
API Access
Gsk EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=GSK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();